FDA Nonprescription Office Expects Progress On Sunscreen Monograph
This article was originally published in The Rose Sheet
Executive Summary
With added expertise in the FDA's Division of Nonprescription Regulation Development, the division aims to make headway on the long-delayed OTC sunscreen monograph